Abstract
Objective: The authors report a survey of the American Association of Directors of Psychiatry Residency Training (AADPRT) on interactions between the pharmaceutical industry and psychiatry residency programs. Methods: American Association of Directors of Psychiatry Residency Training membership was anonymously surveyed by e-mail and by paper distribution at the 2002 annual meeting. Results: Twenty-seven percent of AADPRT members participated. Lunches for residents were the most common interaction, reported by 93% of programs, nearly all of which permitted literature and gifts to be distributed. Only 4% required faculty to be present. Retreats (27%) and travel funds (34%) were sponsored less frequently. One third of programs had written policies governing these interactions, but half of respondents did not know if their parent institutions had such policies. A minority of programs (40%) had formal didactic instruction for residents on this topic. Support for more information, direction, and teaching was widespread. Conclusions: The authors recommend more structured teaching and the establishment of formal program and institutional policies to govern these interactions.
Similar content being viewed by others
References
Hodges B: Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns, and clerks. CMAJ 1995; 153: 553–559
American Medical Association, Council of Ethical and Judicial Affairs: Gifts to physicians from industry. JAMA 1991; 265: 501
American Medical Association, Committee on Education: Ethical guidelines for gifts to physician from industry. Available at http://www.ama-assn.org/ama/pub/category/5689.html. Accessibility verified 3/8/04.
American College of Graduate Medical Education: Principles to guide the relationship between graduate medical education and industry. ACGME 9/10/02. Available at: http://www.acgme.org/New/GMEGuide.doc. Accessibility verified on 3/2/04.
Steinman MA: Gifts to physicians in the consumer marketing era. JAMA 2000; 284: 2243
Santana S: AAMC Executive Council sets guidelines on industry marketing to residents. AAMC Reporter, April 2003. Available at: http://www.aamc.org/newsroom/reporter/april03/executivecouncil.htm. Accesibility verified on 3/3/04.
Ferguson RP, Rhim E, Belizaire W, et al: Encounters with pharmaceutical sales representatives among practicing internists. Am J Med 1999; 107: 149–152
Sergeant MD, Hodgetts PG, Godwin M, et al: Interactions with the pharmaceutical industry. CMAJ 1966; 155: 1243–1248
Reeder M, Dougherty J, White LJ: Pharmaceutical representatives and emergency medicine residents. Ann Emerg Med 1993; 22: 105–108
Pharmaceutical Research and Manufacturers of America: PhRMA code on interactions with healthcare professionals. Available at http://www.phrma.org. Accessibility verified 3/8/04.
Brotzman GL, Mark DH: Policies regulating the activities of pharmaceutical representatives in residency programs. J Fam Pract 1992; 34: 154–157
Mahood S, Zagozeski C, Bradel T, et al: Pharmaceutical policies in Canadian family medicine training: survey of residency programs. Can Fam Physician 1997; 43: 1947–1951
Steinman MA, Shilpak MG, McPhee SJ: Of principles and pens: attitudes of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110: 551–557
Lichstein PR, Turner RC, O’Brien K: Impact of pharmaceutical company representatives on internal medicine residency programs: a survey of residency program directors. Arch Intern Med 1992; 152: 1009–1013
Reeder M, Dougherty J, White LJ: Pharmaceutical representatives and emergency medicine residents. Ann Emerg Med 1993; 22: 105–108
Keim SM, Sanders AB, Witzke DB, et al: Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry. Ann Emerg Med 1993; 22: 1576–1581
Rosack J: Residents want education on interacting with drug industry. Psychiatr News 2001; 36: 18
Sierles FS, Magrane D: Psychiatry clerkship directors: who they are, what they do, and what they think. Psychiatr Q 1996; 67: 153–162
Vinson DC, McCandless B, Hosokawa MC: Medical students’ attitudes toward pharmaceutical marketing: possibilities for change. Fam Med 1993; 25: 31–33
Wilkes M, Hoffman J: An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 2001; 76: 1271–1277
Brotzman G, Mark D: The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med 1993; 8: 130–134
Hopper JA, Speece MW, Musial JL: Effects of an educational intervention on residents’ knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med 1997; 12: 639–642
McCormick BB, Tomlinson G, Brill-Edwards P, et al: Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001; 286: 1994–1999
Shaugnessy AF, Slawson DC, Bennett JH: Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med 1995; 27: 581–585
Brodkey A, Sierles FS: Psychiatry education and the pharmaceutical industry: issues and responses. Teach Learn Med 2003;15: 68–69
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Varley, C.K., Jibson, M.D., McCarthy, M. et al. A Survey of the Interactions Between Psychiatry Residency Programs and the Pharmaceutical Industry. Acad Psychiatry 29, 40–46 (2005). https://doi.org/10.1176/appi.ap.29.1.40
Published:
Issue Date:
DOI: https://doi.org/10.1176/appi.ap.29.1.40